Brickell Stock Performance

BBI -  USA Stock  

USD 0.18  0.01  5.26%

The firm shows a Beta (market volatility) of 2.0425, which signifies a somewhat significant risk relative to the market. Let's try to break down what Brickell's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Brickell Biotech will likely underperform. Even though it is essential to pay attention to Brickell Biotech historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy towards foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Brickell Biotech exposes twenty-seven different technical indicators, which can help you to evaluate its performance. Brickell Biotech has an expected return of -0.24%. Please be advised to confirm Brickell Biotech information ratio, value at risk, kurtosis, as well as the relationship between the sortino ratio and semi variance to decide if Brickell Biotech performance from the past will be repeated at some point in the near future.
  
Refresh
Brickell Performance
0 of 100
Over the last 90 days Brickell Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in June 2022. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more

Brickell Price Channel

Quick Ratio5.59
Fifty Two Week Low0.1783
Target High Price4.00
Fifty Two Week High1.0400
Target Low Price2.00

Brickell Biotech Relative Risk vs. Return Landscape

If you would invest  25.00  in Brickell Biotech on February 17, 2022 and sell it today you would lose (7.00)  from holding Brickell Biotech or give up 28.0% of portfolio value over 90 days. Brickell Biotech is generating negative expected returns assuming volatility of 7.7469% on return distribution over 90 days investment horizon. In other words, 66% of stocks are less volatile than Brickell, and above 99% of all equities are expected to generate higher returns over the next 90 days.
 Daily Expected Return (%) 
      Risk (%) 
Considering the 90-day investment horizon Brickell Biotech is expected to under-perform the market. In addition to that, the company is 5.97 times more volatile than its market benchmark. It trades about -0.03 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.06 per unit of volatility.

Brickell Biotech Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Brickell Biotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Brickell Biotech, and traders can use it to determine the average amount a Brickell Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0309

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsBBI
Estimated Market Risk
 7.75
  actual daily
 
 66 %
of total potential
 
6666
Expected Return
 -0.24
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.03
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Brickell Biotech is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Brickell Biotech by adding it to a well-diversified portfolio.

About Brickell Biotech Performance

To evaluate Brickell Biotech Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Brickell Biotech generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Brickell Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Brickell Biotech stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Brickell's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Return on Average Assets(1.30) (1.33) 
Return on Average Equity(1.64) (1.68) 
Return on Invested Capital 15.43  16.65 
Return on Sales(97.54) (100.10) 
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company was founded in 2009 and is headquartered in Boulder, Colorado. Brickell Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.

Things to note about Brickell Biotech

Checking the ongoing alerts about Brickell Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Brickell Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Brickell Biotech Alerts

Equity Alerts and Improvement Suggestions

Brickell Biotech generated a negative expected return over the last 90 days
Brickell Biotech has high historical volatility and very poor performance
Brickell Biotech has some characteristics of a very speculative penny stock
Brickell Biotech has high likelihood to experience some financial distress in the next 2 years
Brickell Biotech was previously known as BRICKELL BIOTECH INC and was traded on NASDAQ Exchange under the symbol VICL.
The company reported the last year's revenue of 404 K. Reported Net Loss for the year was (39.47 M) with loss before taxes, overhead, and interest of (27.83 M).
Brickell Biotech has about 26.88 M in cash with (36.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Brickell Biotech has a frail financial position based on the latest SEC disclosures
Latest headline from www.marketscreener.com: BRICKELL BIOTECH, INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Marketscreener.com
Continue to Trending Equities. Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Brickell Stock analysis

When running Brickell Biotech price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Brickell Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.